Nord/LB Analysts Give Fresenius Medical Care AG & Co. KGaA (FME) a €85.00 Price Target

Nord/LB set a €85.00 ($98.84) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report released on Wednesday morning. The firm currently has a buy rating on the stock.

A number of other research analysts have also recently weighed in on the stock. JPMorgan Chase & Co. set a €97.90 ($113.84) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Wednesday. Commerzbank set a €80.00 ($93.02) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Wednesday. Goldman Sachs Group set a €98.00 ($113.95) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Wednesday. Sanford C. Bernstein set a €107.00 ($124.42) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Wednesday. Finally, Berenberg Bank set a €100.80 ($117.21) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Wednesday. Nine analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Fresenius Medical Care AG & Co. KGaA presently has an average rating of Buy and a consensus target price of €92.77 ($107.87).

Shares of FME stock opened at €70.10 ($81.51) on Wednesday. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of €75.53 ($87.83) and a fifty-two week high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

See Also: Compound Annual Growth Rate (CAGR)

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply